news & meetings - latest announcements & happenings | oneFAPvoice

welcome to oneFAPvoice

- a positively charged Familial Adenomatous Polyposis community.
  • join today!
https://media-www.fapvoice.com/wp-content/uploads/2018/06/European-Hereditary-Tumour-Group_3rdmeet.jpg
happenings

European Hereditary Tumour Group 3rd Meeting 2018

Dates: 23-25 September 2018 (Sunday to Tuesday) Venue: Radisson Blu Hotel, Nice, France On behalf of the European Hereditary Tumour Group (EHTG), we are delighted to invite you to the 2018 EHTG meeting being held in charming Nice along the Côte d’Azur. The meeting is mostly interdisciplinary and offers the unique setting of attracting scientists and clinicians from many different disciplines such as genetics, pathology, immunology, gastroenterology, epidemiology, surgery, psychology among others.  
Sep 23, 2018
https://media-www.fapvoice.com/wp-content/uploads/2017/11/hcistudyiden-1.jpg
clinical trials

Study identifies enhanced impact of treatment for hereditary cancer patients

People with an inherited syndrome called familial adenomatous polyposis (FAP) have a 100% lifetime risk of developing colorectal cancer if they do not seek appropriate medical care. Recent findings published by researchers at Huntsman Cancer Institute at the University of Utah identified a promising prevention treatment for patients with FAP. A new study takes these findings a step further by reporting that the treatment led to a near-complete blockade of cancer growth pathways in polyps isolated from FAP patients. Further, these patients showed evidence of activated immune responses aimed at destroying pre-cancerous polyps. The findings were published today in the journal Cancer Prevention Research.
Nov 6, 2017